Women report decreased vaginal dryness, increased frequency of intercourse
FRIDAY, Sept. 22, 2017 (HealthDay News) — Use of a fractional carbon dioxide (CO2) laser is a safe and effective treatment for genitourinary symptoms of menopause (GSM), according to a study published online Sept. 7 in Lasers in Surgery and Medicine.
Patrick Lang, M.D., from The Christ Hospital in Cincinnati, and colleagues assessed patient satisfaction with treatment outcomes and out-of-pocket expense for the fractional CO2 laser (SmartXide) in the treatment of GSM (122 patients).
The researchers found that patient-reported vaginal dryness significantly improved following treatment (P < 0.05). There was an increase in the frequency of intercourse from “once a month” to “few times a month” (P < 0.001). The majority of patients (86 percent) reported satisfaction with their treatment results and with the cost of treatment (78 percent).
“This treatment is associated with a high level of patient satisfaction with both treatment results and out-of-pocket expense,” the authors write.
Oral Menopausal Hormone Therapy Linked to Venous Thromboembolic Risk 
MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms 
Longer Reproductive Lifespan Tied to Lower Bronchiectasis Risk in Postmenopausal Women 
Midlife Onset of Increasing Pulse Pressure Not Linked to Menopause .jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
Isometric Exercise Training Three Times a Week Preserves Cardiovascular Benefits 
IBD Not Linked to Risk for Hypertensive Disorders of Pregnancy Overall 
Mortality in Injured Children Linked to Higher SBP Thresholds Than Those That Define Hypotension 
.jpg)
